Harrow Health, Inc. (NASDAQ:HROW) Position Trimmed by Invict

Invictus Private Wealth LLC lowered its stake in Harrow Health, Inc. (NASDAQ:HROW – Free Report) by 17.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 639,316 shares of the company’s stock after selling 134,806 shares during the period. Harrow Health makes up about 1.6% […]

Related Keywords

Markl Baum , Martina Makary , Zurcher Kantonalbank Zurich Cantonalbank , Securities Exchange Commission , Quarter For Harrow Health , News Ratings For Harrow Health Daily , Pharmaceuticals Inc , Marshall Wace , Eton Pharmaceuticals Inc , Mendota Financial Group , Harrow Health , Insider Transactions At Harrow Health , Surface Ophthalmics Inc , Invictus Private Wealth , Harrow Health Stock Down , Jump Financial , Nasdaq , Harrow Health Company Profile , Harrow Health Inc , Free Report , Private Wealth , Financial Group , Director Martin , Exchange Commission , Health Stock Down , Get Free Report , Surface Ophthalmics , Melt Pharmaceuticals , Eton Pharmaceuticals , Visit Holdingschannel , Harrow Health Daily , Nasdaq Hrow , Throw , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,